Lactobacillus acidophilus Expressing Recombinant K99 Adhesive Fimbriae Has an Inhibitory Effect on Adhesion of Enterotoxigenic Escherichia coli
0301 basic medicine
Dose-Response Relationship, Drug
Escherichia coli Vaccines
Swine
Escherichia coli Proteins
Immunology
Bacterial Toxins
Genetic Vectors
In Vitro Techniques
Microbiology
Bacterial Adhesion
Recombinant Proteins
3. Good health
Intestines
Lactobacillus acidophilus
03 medical and health sciences
Virology
Fimbriae, Bacterial
Antigens, Surface
Animals
Escherichia coli Infections
DOI:
10.1111/j.1348-0421.2005.tb03687.x
Publication Date:
2013-11-14T15:08:45Z
AUTHORS (11)
ABSTRACT
AbstractThe most common enteric colibacillosis in neonatal and newborns is caused by enterotoxigenic Escherichia coli (ETEC). Colonization of ETEC in the small intestine is associated with adhesions using fimbriae, which is known as a specific adhesion factor and provides highly specific means for anchoring and prerequisite for an infectious agent. In the present study we have engineered Lactobacillus acidophilus to produce recombinant K99 fimbriae, which is used for the colonization to the intestine of pigs. The expression of K99 fimbrial protein was confirmed using SDS‐PAGE, immunoblot and agglutination analyses. To evaluate a function of the K99 fimbrial protein, inhibition and competition tests were performed on pre‐screened intestinal brush border from pigs. The tests showed that recombinant L. acidophilus, not control L. acidophilus, had a significant inhibitory effect to and competition against K99+ E. coli in a dose dependent manner. In conclusion, we demonstrated that recombinant K99 fimbriae producing L. acidophilus was able to prevent E. coli binding to intestinal brush border.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (29)
CITATIONS (33)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....